The Importance of Muscle Function in Patients With Disseminated Bladder Cancer

The Importance of Muscle Function in Patients With Disseminated Bladder Cancer

This study investigates if reduced muscle mass and muscle function predispose to poor completion of oncological treatment in patients with bladder cancer (including cancer of the renal pelvis, ureter and urethra) and if muscle mass and muscle function change during oncological treatment in these patients. It also evaluates biomarkers for sarcopenia.

Inclusion Criteria:

• Informed consent
• Age ≥ 18 år
• Histologically verified cancer of the renal pelvis, ureter, bladder or urethra regardless of type of histology
• ECOG performance status 0 - 3
• Meet the requirements for receiving oncological treatment (neoadjuvant chemotherapy for localized disease, chemotherapy or immunotherapy for disseminated disease).

Exclusion Criteria:

• Age < 18